Findings support shorter course of radiation therapy after breast lumpectomy

August 06, 2002

A shorter, more convenient course of radiation therapy after breast lumpectomy appears to be just as effective as the longer, more standard, regimen, according to new research appearing in the August 7 issue of the Journal of the National Cancer Institute.

Radiation therapy after a lumpectomy substantially reduces the risk of breast cancer recurrence. However, researchers have not come to a consensus about the most appropriate length of radiation therapy that a patient should receive. In the United States, radiation is delivered in smaller doses over a several weeks, but in the United Kingdom and Canada, larger doses of radiation are delivered over a shorter period of time.

To determine which strategy is most effective, Timothy Whelan, B.M., B.Ch., M.Sc., of the Hamilton Regional Cancer Centre in Ontario, and his colleagues compared breast cancer recurrence and cosmetic outcome among 1,234 women randomly assigned to receive either a more intensive course of radiation over 22 days or a less intensive regimen over 35 days. All of the women had undergone lumpectomies for invasive breast cancers that had not spread to the lymph nodes.

Nearly 6 years later, the shortened course did not result in increased recurrence of breast cancer or result in a worse cosmetic outcome. Local recurrence-free survival at five years was 97.2% in the group receiving a shorter course of therapy, compared with 96.8% in the group receiving an extended course of therapy. There was no difference in disease-free or overall survival. Further, the cosmetic outcome was similar and excellent or good in the majority of patients in both groups. Toxic effects from radiation, such as damage to the skin, were rare in both groups.

The authors note that these findings may have important implications. "A shorter fractionation schedule will lessen the burden of treatment for women, many of whom may also receive adjuvant chemotherapy, and will have important quality-of-life benefits with respect to convenience and less time away from home and work," they write.

In an accompanying editorial, Carolyn I. Sartor, M.D., and Joel E. Tepper, M.D., of the University of North Carolina School of Medicine, ask whether this study sets a new standard for adjuvant radiation for early-stage breast cancer. It may for some women, they say, but they caution that these results only apply to women who have small tumors that have been completely removed. For these women, they say, it may be possible to make therapy shorter, more convenient, and less expensive.
-end-
Contact: Christine Naugler, Cancer Care Ontario, (416) 971-9800, ext. 1605, fax: (416) 217-1249; Christine.naugler@cancercare.on.ca

Editorial: Dianne Shaw, UNC Lineberger Comprehensive Cancer Center, (919) 966-5905, fax: (919) 966-9727; dgs@med.unc.edu

Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94:1143-50.

Editorial: Sartor C, Tepper J. Is less more?: Lessons in radiation schedules in breast cancer. J Natl Cancer Inst 2002;94:1114-5.

Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.